Role of Merck: Innovation to Advance Diabetes Education
As a global, research-driven pharmaceutical company, Merck is dedicated to putting patients first. For nearly 100 years, Merck has discovered, developed, manufactured, and marketed novel medicines and vaccines that have delivered true advances in patient care for people around the world.
Merck is a proud sponsor of the Journey for Control program. Through this initiative, we are committed to working with health plans and each of the partners who are instrumental in providing diabetes care, in order to counter the prevalence of the disease and provide hope for brighter futures. As part of that commitment, the Journey for Control program provides free, comprehensive, and unbiased educational materials and practical disease-management resources to help keep patients informed and healthy.
Since effective management of type 2 diabetes involves all of the diabetes-care stakeholders—patients, physicians, educators, and insurers—Journey for Control also stresses the importance of combining professional guidance with information. This is a method to reinforce behavioral change and help patients become proactive health managers on a daily basis. It takes knowledge, action, and an integrated approach to battle an epidemic like diabetes. We remain confident that positive action can be taken when we all work together.
